NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...
NervGen Pharma to Present at the 63rd International Spinal Cord Society Annual Scientific Meeting
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...
The Globe and Mail5d
NervGen Pharma to Present at the 63rd International Spinal Cord Society Annual Scientific Meeting
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions ...
Stifel Nicolaus Sticks to Its Buy Rating for Cipher Pharmaceuticals (CPHRF)
Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Cipher Pharmaceuticals (CPHRF – Research Report) today and set a price ...
Investing1d
Kairos Pharma Ltd (KAPA)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
moneycontrol.com3d
Mankind Pharma to consider fund raise on September 24
Mankind Pharma said on September 18 that its board will convene next week to consider a proposal to raise funds through the issuance of securities. The board meeting is scheduled for September 24 ...
STAT5d
The essential biotech updates of the day
Ascendis Pharma reported positive results from a Phase 3 study of Transcon CNP in children with achondroplasia, the most common form of dwarfism. Children treated with the Ascendis drug grew an ...
Indiatimes5d
‘Give clarity on pharma city project’
Hyderabad: BRS working chief, former industries minister KT Rama Rao on Sunday shot off a letter to chief minister A Revanth Reddy seeking clarity on continuation of pharma city project The former ...